Biotech

Career and Jobs News

Biotech Career and Jobs Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech

Top news of the week: 31.03.2022.

#biotech
#HealthcareNews
#ClinicalResearchNews
#PharmiwebNews
#PharmaNews
#MedicalNews
#BiotechNews
#LifeSciencesNews
#cancer
#cyber

Career And Jobs

@NatureBiotech shared
On Mar 28, 2022
@UNC_Health_Care Implants speed CAR T cell processing in vivo, treating lymphoma in mice #NBTintheNews via @GENbio https://t.co/pmQ2esIztl
Open
Implants Speed CAR T Cell Processing In Vivo, Treating Lymphoma in Mice

Implants Speed CAR T Cell Processing In Vivo, Treating Lymphoma in Mice

MASTER scaffolds carry out T-cell activation, reprogramming, and expansion inside the patient, transforming a multi-week process into a single-day procedure.

@pharminews shared
On Mar 29, 2022
Rentschler Biopharma and Vetter Unveil Xpert Alliance, a Joint Visualization of their Successful Strategic Collaboration https://t.co/XvPAPOMdD9 #PharmaNews #ClinicalResearchNews #BiotechNews #LifeSciencesNews #MedicalNews #HealthcareNews #PharmiwebNews https://t.co/ODN5zSQnkn
Open
Rentschler Biopharma and Vetter Unveil Xpert Alliance, a Joint Visualization of their Successful Strategic Collaboration

Rentschler Biopharma and Vetter Unveil Xpert Alliance, a Joint Visualization of their Successful Strategic Collaboration

Rentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organizations (CDMOs), announced today that the companies are unveiling Xpert Alliance, a ...

@biospace shared
On Mar 25, 2022
The cyber threats emanating from Russia, China and North Korea aimed at the West can affect biotech companies in very real ways, either directly or as collateral damage. #cyber #biotech https://t.co/rzOVPBynhW
Open
Automation Makes Biopharma a Prime Target for Cyber Attacks: Be Ready

Automation Makes Biopharma a Prime Target for Cyber Attacks: Be Ready

The cyber threats emanating from Russia, China and North Korea aimed at the West can affect biotech companies in very real ways, either directly or as collateral damage. 

@JohnCendpts shared
On Mar 25, 2022
RT @ZacharyBrennan: Another sign of FDA getting tougher on accelerated approvals. $MEIP CEO (-45% premarket): "FDA’s current position on the assessment of benefit and risk of PI3K inhibitors solely based on single arm studies appears to have evolved" via @AmberTongPW https://t.co/AuuAGXvRsf
Open
No more accelerated approvals for PI3K? Biotech cites FDA's 'current position' as it warns of major delay

No more accelerated approvals for PI3K? Biotech cites FDA's 'current position' as it warns of major delay

Did the FDA change its mind about the class of cancer drugs known as PI3K? Whereas the agency had previously granted accelerated approvals to PI3K drugs, that option is apparently off the ...

@JohnCendpts shared
On Mar 24, 2022
Into designing proteins? Here's a must read from @Jasonmmast ‘A major step forward': Scientists unveil new approach for designing protein drugs against any target https://t.co/HAEKL5BOOz
Open
‘A major step forward': Scientists unveil new approach for designing protein drugs against any target

‘A major step forward': Scientists unveil new approach for designing protein drugs against any target

When Longxing Cao arrived as a postdoc at the University of Washington in 2017, David Baker's lab was already known as the leader in a niche field of designing new proteins from scratch. ...

@Labiotech_eu shared
On Mar 29, 2022
.@Labiotech_eu & @inova_io are bringing you exclusive coverage of the top insights from #BIOEuropeSpring2022! Keep a close eye on this page as we regularly add key take-home reports from the proceedings 👉🏻 https://t.co/sklodzB9oD 👈🏻 @EBDgroup #biotech #biopharmapartnering https://t.co/1mca60AndP
Open
BIO-Europe Spring 2022: The Highlights

BIO-Europe Spring 2022: The Highlights

BIO-Europe Spring is one of Europe's biggest biotech partnering events with discussion topics ranging from platform technologies and manufacturing to biotech investments. Here are some of ...

@biospace shared
On Mar 29, 2022
Before cell and gene therapy can truly become mainstream medicine, the challenges of allogeneic rejection and targeted delivery must be solved. Sana Biotechnology is on the path to do that. #SanaBiotechnology #CellTherapy #GeneTherapy #BioSpace https://t.co/j45ZyWbaTA
Open
Sana On Track to Remove Barriers for Cell & Gene Therapy

Sana On Track to Remove Barriers for Cell & Gene Therapy

Before cell and gene therapy can truly become mainstream medicine, the challenges of allogeneic rejection and targeted delivery must be solved. Sana Biotechnology is on the path to do that.

@JohnCendpts shared
On Mar 26, 2022
The Endpoints News Weekly edition is out with a look at the week that was -- by @AmberTongPW ALS drug sets the stage for fresh FDA debate; Implosions everywhere you look; Big names turn up at biotechs; and more https://t.co/UHHvEXCyaU
Open
ALS drug sets the stage for fresh FDA debate; Implosions everywhere you look; Big names turn up at biotechs; and more

ALS drug sets the stage for fresh FDA debate; Implosions everywhere you look; Big names turn up at biotechs; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader ...

Read more: Career And Jobs
weekly 31.03.2022
View archives
Back to home

Subscribe to Biotech - Career and Jobs.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech - Career and Jobs.
Privacy Policy

Sign up for the weekly Biotech - Career and Jobs newsletter

Never again miss anything or anyone that matter in Biotech

Sign up and receive the Biotech - Career and Jobs weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy